Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse.

Chen J, Kawamura T, Sethi MK, Zaia J, Repunte-Canonigo V, Sanna PP.

Sci Rep. 2017 Oct 24;7(1):13931. doi: 10.1038/s41598-017-13960-6.

2.

Similar precipitated withdrawal effects on intracranial self-stimulation during chronic infusion of an e-cigarette liquid or nicotine alone.

Harris AC, Muelken P, Smethells JR, Krueger M, LeSage MG.

Pharmacol Biochem Behav. 2017 Oct;161:1-5. doi: 10.1016/j.pbb.2017.08.011. Epub 2017 Sep 1.

PMID:
28867606
3.

Nicotine Vapor Method to Induce Nicotine Dependence in Rodents.

Kallupi M, George O.

Curr Protoc Neurosci. 2017 Jul 5;80:8.41.1-8.41.10. doi: 10.1002/cpns.34.

PMID:
28678400
4.

Neuroclinical Framework for the Role of Stress in Addiction.

Kwako LE, Koob GF.

Chronic Stress (Thousand Oaks). 2017 Feb;1. doi: 10.1177/2470547017698140. Epub 2017 Apr 10.

PMID:
28653044
5.

Reward Processing and Smoking.

Bruijnzeel AW.

Nicotine Tob Res. 2017 Jun 1;19(6):661-662. doi: 10.1093/ntr/ntw303. No abstract available.

PMID:
28486714
6.

Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.

Cook JW, Lanza ST, Chu W, Baker TB, Piper ME.

Nicotine Tob Res. 2017 Jun 1;19(6):703-709. doi: 10.1093/ntr/ntw247.

PMID:
28486709
7.

Special issue: recognizing the lifetime scientific contributions of Athina Markou.

Cryan JF, de Wit H.

Psychopharmacology (Berl). 2017 May;234(9-10):1311-1313. doi: 10.1007/s00213-017-4624-7. No abstract available.

PMID:
28421256
8.

Role of perineuronal nets in the anterior dorsal lateral hypothalamic area in the acquisition of cocaine-induced conditioned place preference and self-administration.

Blacktop JM, Todd RP, Sorg BA.

Neuropharmacology. 2017 May 15;118:124-136. doi: 10.1016/j.neuropharm.2017.03.018. Epub 2017 Mar 18.

PMID:
28322980
9.

In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.

Jackson A, Bagdas D, Muldoon PP, Lichtman AH, Carroll FI, Greenwald M, Miles MF, Damaj MI.

Neuropharmacology. 2017 May 15;118:38-45. doi: 10.1016/j.neuropharm.2017.03.005. Epub 2017 Mar 7.

PMID:
28279662
10.

Neuropeptide systems and new treatments for nicotine addiction.

Bruijnzeel AW.

Psychopharmacology (Berl). 2017 May;234(9-10):1419-1437. doi: 10.1007/s00213-016-4513-5. Epub 2016 Dec 28. Review.

PMID:
28028605
11.

Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective.

Besson M, Forget B.

Front Psychiatry. 2016 Sep 21;7:160. eCollection 2016. Review.

12.

Using Multigroup-Multiphase Latent State-Trait Models to Study Treatment-Induced Changes in Intra-Individual State Variability: An Application to Smokers' Affect.

Geiser C, Griffin D, Shiffman S.

Front Psychol. 2016 Jul 22;7:1043. doi: 10.3389/fpsyg.2016.01043. eCollection 2016.

13.

Overexpression of CRF in the BNST diminishes dysphoria but not anxiety-like behavior in nicotine withdrawing rats.

Qi X, Guzhva L, Yang Z, Febo M, Shan Z, Wang KKW, Bruijnzeel AW.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1378-1389. doi: 10.1016/j.euroneuro.2016.07.007. Epub 2016 Jul 22.

14.

Progression of nicotine dependence, mood level, and mood variability in adolescent smokers.

Piasecki TM, Hedeker D, Dierker LC, Mermelstein RJ.

Psychol Addict Behav. 2016 Jun;30(4):484-93. doi: 10.1037/adb0000165. Epub 2016 Mar 14.

15.

Cognitive control deficits during mecamylamine-precipitated withdrawal in mice: Possible links to frontostriatal BDNF imbalance.

Parikh V, Cole RD, Patel PJ, Poole RL, Gould TJ.

Neurobiol Learn Mem. 2016 Feb;128:110-6. doi: 10.1016/j.nlm.2016.01.003. Epub 2016 Jan 13.

16.

A Two-Day Continuous Nicotine Infusion Is Sufficient to Demonstrate Nicotine Withdrawal in Rats as Measured Using Intracranial Self-Stimulation.

Muelken P, Schmidt CE, Shelley D, Tally L, Harris AC.

PLoS One. 2015 Dec 11;10(12):e0144553. doi: 10.1371/journal.pone.0144553. eCollection 2015.

17.

Blockade of cholinergic transmission elicits somatic signs in nicotine-naïve adolescent rats.

Schmidt CE, Manbeck KE, Shelley D, Harris AC.

Front Pharmacol. 2015 Oct 20;6:239. doi: 10.3389/fphar.2015.00239. eCollection 2015.

18.

Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.

Wiebelhaus JM, Walentiny DM, Beardsley PM.

J Pharmacol Exp Ther. 2016 Jan;356(1):43-52. doi: 10.1124/jpet.115.228940. Epub 2015 Oct 21.

19.

Motivational Processes Underlying Substance Abuse Disorder.

Meyer PJ, King CP, Ferrario CR.

Curr Top Behav Neurosci. 2016;27:473-506. Review.

20.

The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.

Blum K, Thompson B, Demotrovics Z, Femino J, Giordano J, Oscar-Berman M, Teitelbaum S, Smith DE, Roy AK, Agan G, Fratantonio J, Badgaiyan RD, Gold MS.

J Reward Defic Syndr. 2015;1(1):46-64.

Supplemental Content

Support Center